Transformation of Indian pharmaceutical industry making it attractive for investment

The Indian pharmaceutical industry has come a long way from waiting for imports of bulk drugs from global majors for re-processing to becoming an industry which is driving product development and breaking new grounds in medicine research worldwide, notes a new report from Aruvian Research.

This transformation can be better gauged in terms of volume numbers where, in the industry which was earlier stagnating, it is now expected to touch a turnover of 250 billion rupees ($5.7 billion) at the end of the 10th Five Year Plan (2002-2007). Part of this amazing growth story will be propelled by capital investments of around 100 billion rupees ($2.3 billion), most of which have already been committed to the government of India.

The Indian pharmaceutical industry has a unique amalgamation of three critical factors which make it so attractive for investment thereby adding impetus to growth.